Go Viral Ltd. is a preclinical stage biotechnology company developing recombinant oncolytic virusesand immunotherapy for cancer along with a theranostic biomarker-based kit for sensitivity, specificity, and monitoring. The company is a subsidiary of Rapo Yerapeh which was founded in 2016.